Neurology

>

Latest News

 Marinus discontinuing oral ganaxolone trial development for treatment of seizures in children | Image Credit: © SewcreamStudio - © SewcreamStudio - stock.adobe.com.
Marinus discontinuing oral ganaxolone trial development to treat seizures in children

October 24th 2024

The TrustTSC trial did not achieve its primary endpoint of percent reduction in 28-day frequency of TSC-associated seizures.

FDA approves sodium oxybate to treat cataplexy, EDS in pediatric narcolepsy patients | Image Credit: © Calin - © Calin - stock.adobe.com.
FDA approves sodium oxybate to treat cataplexy, EDS in pediatric narcolepsy patients

October 17th 2024

Discussing genetic diagnoses with parents can be tricky | Image credit: Contemporary Pediatrics
Discussing genetic diagnoses with parents can be tricky

October 14th 2024

Offspring seizure risk associated with maternal influenza | Image Credit: © adipurnatama - © adipurnatama - stock.adobe.com.
Offspring seizure risk associated with maternal influenza

September 25th 2024

Arimoclomol approved as first drug to treat Neimann-Pick disease | Image Credit: © John Doe - © John Doe - stock.adobe.com.
FDA approves arimoclomol as first drug to treat Neimann-Pick disease, type C

September 20th 2024

More News

© 2024 MJH Life Sciences

All rights reserved.